Summit Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | 05/15/2025 | 24.42 M | $471.16 M | 0.00% | 3.31% |
VANGUARD GROUP INC | 05/09/2025 | 11.64 M | $224.55 M | -0.26% | 1.58% |
FMR LLC | 05/12/2025 | 9.34 M | $180.13 M | 15.93% | 1.27% |
BLACKROCK, INC. | 05/02/2025 | 8.40 M | $161.99 M | -0.40% | 1.14% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 6.56 M | $126.50 M | 0.00% | 0.89% |
STATE STREET CORP | 05/15/2025 | 4.85 M | $93.58 M | -13.41% | 0.66% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 3.28 M | $63.38 M | 2.63% | 0.45% |
PICTET ASSET MANAGEMENT HOLDING SA | 05/05/2025 | 2.66 M | $52.14 M | 91.86% | 0.36% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 1.70 M | $32.85 M | 339.82% | 0.23% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.46 M | $28.18 M | -1.64% | 0.20% |
UBS GROUP AG | 05/13/2025 | 1.26 M | $24.39 M | 6.56% | 0.17% |
ABRDN PLC | 05/13/2025 | 1.20 M | $23.16 M | -6.94% | 0.16% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 1.10 M | $21.19 M | 122.73% | 0.15% |
CITADEL ADVISORS LLC | 05/15/2025 | 998.74 K | $19.27 M | 432.93% | 0.14% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2025 | 995.00 K | $19.19 M | -5.60% | 0.13% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 887.01 K | $17.11 M | -56.73% | 0.12% |
NORTHERN TRUST CORP | 05/13/2025 | 843.65 K | $16.27 M | -3.18% | 0.11% |
CANDRIAM S.C.A. | 05/14/2025 | 838.52 K | $16.18 M | -0.48% | 0.11% |
TD ASSET MANAGEMENT INC | 05/07/2025 | 807.19 K | $15.57 M | -3.67% | 0.11% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 750.10 K | $14.47 M | 144.49% | 0.10% |
SIREN, L.L.C. | 05/23/2025 | 695.00 K | $13.41 M | 100.00% | 0.09% |
TWIN TREE MANAGEMENT, LP | 05/15/2025 | 653.60 K | $12.61 M | -43.99% | 0.09% |
JPMORGAN CHASE & CO | 05/12/2025 | 575.62 K | $11.10 M | 312.39% | 0.08% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 574.80 K | $11.09 M | 46.22% | 0.08% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 572.79 K | $11.05 M | -37.06% | 0.08% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 538.00 K | $10.38 M | 100.00% | 0.07% |
JANE STREET GROUP, LLC | 05/19/2025 | 506.10 K | $9.76 M | 29.54% | 0.07% |
MORGAN STANLEY | 05/15/2025 | 478.13 K | $9.22 M | -14.77% | 0.06% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 05/15/2025 | 466.16 K | $8.99 M | -2.23% | 0.06% |
DEUTSCHE BANK AG\ | 05/09/2025 | 427.62 K | $8.25 M | -10.69% | 0.06% |
CUTTER CAPITAL MANAGEMENT, LP | 05/15/2025 | 400.00 K | $7.72 M | 100.00% | 0.05% |
POLYMER CAPITAL MANAGEMENT (HK) LTD | 05/15/2025 | 396.18 K | $7.64 M | 80.23% | 0.05% |
CITADEL ADVISORS LLC | 05/15/2025 | 394.60 K | $7.61 M | 25.15% | 0.05% |
INVESCO LTD. | 05/12/2025 | 389.71 K | $7.52 M | -2.34% | 0.05% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 369.22 K | $7.12 M | -14.45% | 0.05% |
QVT FINANCIAL LP | 05/15/2025 | 360.52 K | $6.95 M | 0.00% | 0.05% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 340.78 K | $6.57 M | 2.18% | 0.05% |
TWIN TREE MANAGEMENT, LP | 05/15/2025 | 339.09 K | $6.54 M | -31.61% | 0.05% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 322.10 K | $6.21 M | 100.00% | 0.04% |
E FUND MANAGEMENT CO., LTD. | 05/13/2025 | 295.62 K | $5.70 M | -0.23% | 0.04% |
CITIGROUP INC | 05/12/2025 | 295.42 K | $5.70 M | 16.29% | 0.04% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 286.03 K | $5.52 M | 39.30% | 0.04% |
CITADEL ADVISORS LLC | 05/15/2025 | 256.60 K | $4.95 M | 7.36% | 0.03% |
BARCLAYS PLC | 05/15/2025 | 255.61 K | $4.93 M | -22.58% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 253.50 K | $4.89 M | 228.26% | 0.03% |
GREAT POINT PARTNERS LLC | 05/15/2025 | 250.00 K | $4.82 M | 100.00% | 0.03% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 246.43 K | $4.75 M | 20.12% | 0.03% |
05/12/2025 | 235.89 K | $4.55 M | 100.00% | 0.03% | |
SCHRODER INVESTMENT MANAGEMENT GROUP | 05/13/2025 | 233.60 K | $4.75 M | 100.00% | 0.03% |
RAFFERTY ASSET MANAGEMENT, LLC | 05/14/2025 | 229.74 K | $4.43 M | -26.29% | 0.03% |
Summit Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 229 institutional investors and hedge funds held shares of Summit Therapeutics Inc.. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 24.42 M
VANGUARD GROUP INC: 11.64 M
FMR LLC: 9.34 M
BlackRock, Inc.: 8.4 M
PRICE T ROWE ASSOCIATES INC /MD/: 6.56 M
STATE STREET CORP: 4.85 M
13.24% of Summit Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 110.75 M shares in the last 24 months. This purchase volume represents approximately $2.20 B in transactions.